APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Hydroxyzine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Hydroxyzine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174000850327 December 2025180 pages

Choose your research edition.

Industry ResearchHydroxyzine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Hydroxyzine Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Hydroxyzine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hydroxyzine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Hydroxyzine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Hydroxyzine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Hydroxyzine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hydroxyzine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hydroxyzine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Hydroxyzine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hydroxyzine include GSK, Impax Laboratories, N&R Industries, Novartis, Pfizer, Piramal Group (Piramal Healthcare UK Limited), Shanghai Ruizheng Chemical Technology, Teva Pharmaceuticals and Alliance Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hydroxyzine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hydroxyzine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hydroxyzine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hydroxyzine market size, projected growth trends, production technologies, key applications, and end-use industries.

Hydroxyzine Segment by Company

GSK

Impax Laboratories

N&R Industries

Novartis

Pfizer

Piramal Group (Piramal Healthcare UK Limited)

Shanghai Ruizheng Chemical Technology

Teva Pharmaceuticals

Alliance Pharma

Hydroxyzine Segment by Type

Tablets

Capsules

Other

Hydroxyzine Segment by Application

Hospitals

Retail Pharmacy

Hydroxyzine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxyzine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hydroxyzine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxyzine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hydroxyzine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hydroxyzine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hydroxyzine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hydroxyzine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hydroxyzine Industry Trends Table 2. Hydroxyzine Industry Drivers Table 3. Hydroxyzine Industry Opportunities and Challenges Table 4. Hydroxyzine Industry Restraints Table 5. Global Hydroxyzine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hydroxyzine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hydroxyzine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Hydroxyzine Sales Market Share by Manufacturers Table 9. Global Hydroxyzine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Hydroxyzine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hydroxyzine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hydroxyzine Manufacturers, Product Type & Application Table 13. Global Hydroxyzine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hydroxyzine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablets Table 17. Major Manufacturers of Capsules Table 18. Major Manufacturers of Other Table 19. Global Hydroxyzine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Hydroxyzine Sales by Type (2021-2026) & (K Units) Table 21. Global Hydroxyzine Sales by Type (2027-2032) & (K Units) Table 22. Global Hydroxyzine Sales Market Share by Type (2021-2026) Table 23. Global Hydroxyzine Sales Market Share by Type (2027-2032) Table 24. Global Hydroxyzine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Hydroxyzine Revenue by Type (2021-2026) & (K Units) Table 26. Global Hydroxyzine Revenue by Type (2027-2032) & (K Units) Table 27. Global Hydroxyzine Revenue Market Share by Type (2021-2026) Table 28. Global Hydroxyzine Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospitals Table 30. Major Manufacturers of Retail Pharmacy Table 31. Global Hydroxyzine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Hydroxyzine Sales by Application (2021-2026) & (K Units) Table 33. Global Hydroxyzine Sales by Application (2027-2032) & (K Units) Table 34. Global Hydroxyzine Sales Market Share by Application (2021-2026) Table 35. Global Hydroxyzine Sales Market Share by Application (2027-2032) Table 36. Global Hydroxyzine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Hydroxyzine Revenue by Application (2021-2026) & (K Units) Table 38. Global Hydroxyzine Revenue by Application (2027-2032) & (K Units) Table 39. Global Hydroxyzine Revenue Market Share by Application (2021-2026) Table 40. Global Hydroxyzine Revenue Market Share by Application (2027-2032) Table 41. Global Hydroxyzine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Hydroxyzine Sales by Region (2021-2026) & (K Units) Table 43. Global Hydroxyzine Sales Market Share by Region (2021-2026) Table 44. Global Hydroxyzine Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Hydroxyzine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Hydroxyzine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Hydroxyzine Sales by Country (2021-2026) & (K Units) Table 48. North America Hydroxyzine Sales by Country (2027-2032) & (K Units) Table 49. Europe Hydroxyzine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Hydroxyzine Sales by Country (2021-2026) & (K Units) Table 51. Europe Hydroxyzine Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Hydroxyzine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Hydroxyzine Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Hydroxyzine Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Hydroxyzine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Hydroxyzine Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Hydroxyzine Sales by Country (2027-2032) & (K Units) Table 58. Global Hydroxyzine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Hydroxyzine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Hydroxyzine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Hydroxyzine Revenue Market Share by Region (2021-2026) Table 62. Global Hydroxyzine Revenue Market Share by Region (2027-2032) Table 63. GSK Company Information Table 64. GSK Business Overview Table 65. GSK Hydroxyzine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. GSK Hydroxyzine Product Portfolio Table 67. GSK Recent Development Table 68. Impax Laboratories Company Information Table 69. Impax Laboratories Business Overview Table 70. Impax Laboratories Hydroxyzine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Impax Laboratories Hydroxyzine Product Portfolio Table 72. Impax Laboratories Recent Development Table 73. N&R Industries Company Information Table 74. N&R Industries Business Overview Table 75. N&R Industries Hydroxyzine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. N&R Industries Hydroxyzine Product Portfolio Table 77. N&R Industries Recent Development Table 78. Novartis Company Information Table 79. Novartis Business Overview Table 80. Novartis Hydroxyzine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Novartis Hydroxyzine Product Portfolio Table 82. Novartis Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Hydroxyzine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Pfizer Hydroxyzine Product Portfolio Table 87. Pfizer Recent Development Table 88. Piramal Group (Piramal Healthcare UK Limited) Company Information Table 89. Piramal Group (Piramal Healthcare UK Limited) Business Overview Table 90. Piramal Group (Piramal Healthcare UK Limited) Hydroxyzine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Piramal Group (Piramal Healthcare UK Limited) Hydroxyzine Product Portfolio Table 92. Piramal Group (Piramal Healthcare UK Limited) Recent Development Table 93. Shanghai Ruizheng Chemical Technology Company Information Table 94. Shanghai Ruizheng Chemical Technology Business Overview Table 95. Shanghai Ruizheng Chemical Technology Hydroxyzine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Shanghai Ruizheng Chemical Technology Hydroxyzine Product Portfolio Table 97. Shanghai Ruizheng Chemical Technology Recent Development Table 98. Teva Pharmaceuticals Company Information Table 99. Teva Pharmaceuticals Business Overview Table 100. Teva Pharmaceuticals Hydroxyzine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Teva Pharmaceuticals Hydroxyzine Product Portfolio Table 102. Teva Pharmaceuticals Recent Development Table 103. Alliance Pharma Company Information Table 104. Alliance Pharma Business Overview Table 105. Alliance Pharma Hydroxyzine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Alliance Pharma Hydroxyzine Product Portfolio Table 107. Alliance Pharma Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Hydroxyzine Distributors List Table 111. Hydroxyzine Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Hydroxyzine Product Image Figure 2. Global Hydroxyzine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hydroxyzine Market Size (2021-2032) & (US$ Million) Figure 4. Global Hydroxyzine Sales (2021-2032) & (K Units) Figure 5. Global Hydroxyzine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Hydroxyzine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablets Image Figure 9. Capsules Image Figure 10. Other Image Figure 11. Global Hydroxyzine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Hydroxyzine Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Hydroxyzine Sales Market Share by Type (2021-2032) Figure 14. Global Hydroxyzine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Hydroxyzine Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Hydroxyzine Revenue Market Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Retail Pharmacy Image Figure 19. Global Hydroxyzine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Hydroxyzine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Hydroxyzine Sales Market Share by Application (2021-2032) Figure 22. Global Hydroxyzine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Hydroxyzine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Hydroxyzine Revenue Market Share by Application (2021-2032) Figure 25. North America Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Hydroxyzine Sales Market Share by Country (2021-2032) Figure 27. U.S. Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Hydroxyzine Sales Market Share by Country (2021-2032) Figure 32. Germany Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Hydroxyzine Sales Market Share by Country (2021-2032) Figure 39. China Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Hydroxyzine Sales Market Share by Country (2021-2032) Figure 47. Brazil Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Hydroxyzine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Hydroxyzine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Hydroxyzine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Hydroxyzine Revenue (2021-2032) & (US$ Million) Figure 58. North America Hydroxyzine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Hydroxyzine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Hydroxyzine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Hydroxyzine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Hydroxyzine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Hydroxyzine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Hydroxyzine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Hydroxyzine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Hydroxyzine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Capsules
  • Other
Applications
  • Hospitals
  • Retail Pharmacy
Companies covered
  • GSK
  • Impax Laboratories
  • N&R Industries
  • Novartis
  • Pfizer
  • Piramal Group (Piramal Healthcare UK Limited)
  • Shanghai Ruizheng Chemical Technology
  • Teva Pharmaceuticals
  • Alliance Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hydroxyzine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hydroxyzine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hydroxyzine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hydroxyzine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hydroxyzine Market Dynamics
  1. 2.1 Hydroxyzine Industry Trends
  2. 2.2 Hydroxyzine Industry Drivers
  3. 2.3 Hydroxyzine Industry Opportunities and Challenges
  4. 2.4 Hydroxyzine Industry Restraints
3 Hydroxyzine Market by Manufacturers
  1. 3.1 Global Hydroxyzine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hydroxyzine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hydroxyzine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hydroxyzine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hydroxyzine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hydroxyzine Manufacturers, Product Type & Application
  7. 3.7 Global Hydroxyzine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hydroxyzine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hydroxyzine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hydroxyzine Tier 1, Tier 2, and Tier 3
4 Hydroxyzine Market by Type
  1. 4.1 Hydroxyzine Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Capsules
  4. 4.1.3 Other
  5. 4.2 Global Hydroxyzine Sales by Type
  6. 4.2.1 Global Hydroxyzine Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Hydroxyzine Sales by Type (2021-2032)
  8. 4.2.3 Global Hydroxyzine Sales Market Share by Type (2021-2032)
  9. 4.3 Global Hydroxyzine Revenue by Type
  10. 4.3.1 Global Hydroxyzine Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Hydroxyzine Revenue by Type (2021-2032)
  12. 4.3.3 Global Hydroxyzine Revenue Market Share by Type (2021-2032)
5 Hydroxyzine Market by Application
  1. 5.1 Hydroxyzine Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Retail Pharmacy
  4. 5.2 Global Hydroxyzine Sales by Application
  5. 5.2.1 Global Hydroxyzine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Hydroxyzine Sales by Application (2021-2032)
  7. 5.2.3 Global Hydroxyzine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Hydroxyzine Revenue by Application
  9. 5.3.1 Global Hydroxyzine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Hydroxyzine Revenue by Application (2021-2032)
  11. 5.3.3 Global Hydroxyzine Revenue Market Share by Application (2021-2032)
6 Global Hydroxyzine Sales by Region
  1. 6.1 Global Hydroxyzine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hydroxyzine Sales by Region (2021-2032)
  3. 6.2.1 Global Hydroxyzine Sales by Region (2021-2026)
  4. 6.2.2 Global Hydroxyzine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hydroxyzine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hydroxyzine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hydroxyzine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hydroxyzine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hydroxyzine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hydroxyzine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hydroxyzine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hydroxyzine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hydroxyzine Revenue by Region
  1. 7.1 Global Hydroxyzine Revenue by Region
  2. 7.1.1 Global Hydroxyzine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hydroxyzine Revenue by Region (2021-2026)
  4. 7.1.3 Global Hydroxyzine Revenue by Region (2027-2032)
  5. 7.1.4 Global Hydroxyzine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hydroxyzine Revenue (2021-2032)
  8. 7.2.2 North America Hydroxyzine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hydroxyzine Revenue (2021-2032)
  11. 7.3.2 Europe Hydroxyzine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hydroxyzine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hydroxyzine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hydroxyzine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hydroxyzine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Hydroxyzine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GSK Hydroxyzine Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Impax Laboratories
  8. 8.2.1 Impax Laboratories Company Information
  9. 8.2.2 Impax Laboratories Business Overview
  10. 8.2.3 Impax Laboratories Hydroxyzine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Impax Laboratories Hydroxyzine Product Portfolio
  12. 8.2.5 Impax Laboratories Recent Developments
  13. 8.3 N&R Industries
  14. 8.3.1 N&R Industries Company Information
  15. 8.3.2 N&R Industries Business Overview
  16. 8.3.3 N&R Industries Hydroxyzine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 N&R Industries Hydroxyzine Product Portfolio
  18. 8.3.5 N&R Industries Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Hydroxyzine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Hydroxyzine Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Hydroxyzine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Hydroxyzine Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Piramal Group (Piramal Healthcare UK Limited)
  32. 8.6.1 Piramal Group (Piramal Healthcare UK Limited) Company Information
  33. 8.6.2 Piramal Group (Piramal Healthcare UK Limited) Business Overview
  34. 8.6.3 Piramal Group (Piramal Healthcare UK Limited) Hydroxyzine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Piramal Group (Piramal Healthcare UK Limited) Hydroxyzine Product Portfolio
  36. 8.6.5 Piramal Group (Piramal Healthcare UK Limited) Recent Developments
  37. 8.7 Shanghai Ruizheng Chemical Technology
  38. 8.7.1 Shanghai Ruizheng Chemical Technology Company Information
  39. 8.7.2 Shanghai Ruizheng Chemical Technology Business Overview
  40. 8.7.3 Shanghai Ruizheng Chemical Technology Hydroxyzine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai Ruizheng Chemical Technology Hydroxyzine Product Portfolio
  42. 8.7.5 Shanghai Ruizheng Chemical Technology Recent Developments
  43. 8.8 Teva Pharmaceuticals
  44. 8.8.1 Teva Pharmaceuticals Company Information
  45. 8.8.2 Teva Pharmaceuticals Business Overview
  46. 8.8.3 Teva Pharmaceuticals Hydroxyzine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Teva Pharmaceuticals Hydroxyzine Product Portfolio
  48. 8.8.5 Teva Pharmaceuticals Recent Developments
  49. 8.9 Alliance Pharma
  50. 8.9.1 Alliance Pharma Company Information
  51. 8.9.2 Alliance Pharma Business Overview
  52. 8.9.3 Alliance Pharma Hydroxyzine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Alliance Pharma Hydroxyzine Product Portfolio
  54. 8.9.5 Alliance Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hydroxyzine Value Chain Analysis
  2. 9.1.1 Hydroxyzine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hydroxyzine Production Mode & Process
  6. 9.2 Hydroxyzine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hydroxyzine Distributors
  9. 9.2.3 Hydroxyzine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst